Literature DB >> 29107324

Daytime variation of perioperative myocardial injury in cardiac surgery and its prevention by Rev-Erbα antagonism: a single-centre propensity-matched cohort study and a randomised study.

David Montaigne1, Xavier Marechal2, Thomas Modine3, Augustin Coisne4, Stéphanie Mouton4, Georges Fayad3, Sandro Ninni4, Cédric Klein4, Staniel Ortmans4, Claire Seunes4, Charlotte Potelle5, Alexandre Berthier2, Celine Gheeraert2, Catherine Piveteau6, Rebecca Deprez6, Jérome Eeckhoute2, Hélène Duez2, Dominique Lacroix5, Benoit Deprez6, Bruno Jegou3, Mohamed Koussa3, Jean-Louis Edme5, Philippe Lefebvre2, Bart Staels4.   

Abstract

BACKGROUND: On-pump cardiac surgery provokes a predictable perioperative myocardial ischaemia-reperfusion injury which is associated with poor clinical outcomes. We determined the occurrence of time-of-the-day variation in perioperative myocardial injury in patients undergoing aortic valve replacement and its molecular mechanisms.
METHODS: We studied the incidence of major adverse cardiac events in a prospective observational single-centre cohort study of patients with severe aortic stenosis and preserved left ventricular ejection fraction (>50%) who were referred to our cardiovascular surgery department at Lille University Hospital (Lille, France) for aortic valve replacement and underwent surgery in the morning or afternoon. Patients were matched into pairs by propensity score. We also did a randomised study, in which we evaluated perioperative myocardial injury and myocardial samples of patients randomly assigned (1:1) via permuted block randomisation (block size of eight) to undergo isolated aortic valve replacement surgery either in the morning or afternoon. We also evaluated human and rodent myocardium in ex-vivo hypoxia-reoxygenation models and did a transcriptomic analysis in myocardial samples from the randomised patients to identify the signalling pathway(s) involved. The primary objective of the study was to assess whether myocardial tolerance of ischaemia-reperfusion differed depending on the timing of aortic valve replacement surgery (morning vs afternoon), as measured by the occurrence of major adverse cardiovascular events (cardiovascular death, myocardial infarction, and admission to hospital for acute heart failure). The randomised study is registered with ClinicalTrials.gov, number NCT02812901.
FINDINGS: In the cohort study (n=596 patients in matched pairs who underwent either morning surgery [n=298] or afternoon surgery [n=298]), during the 500 days following aortic valve replacement, the incidence of major adverse cardiac events was lower in the afternoon surgery group than in the morning group: hazard ratio 0·50 (95% CI 0·32-0·77; p=0·0021). In the randomised study, 88 patients were randomly assigned to undergo surgery in the morning (n=44) or afternoon (n=44); perioperative myocardial injury assessed with the geometric mean of perioperative cardiac troponin T release was significantly lower in the afternoon group than in the morning group (estimated ratio of geometric means for afternoon to morning of 0·79 [95% CI 0·68-0·93; p=0·0045]). Ex-vivo analysis of human myocardium revealed an intrinsic morning-afternoon variation in hypoxia-reoxygenation tolerance, concomitant with transcriptional alterations in circadian gene expression with the nuclear receptor Rev-Erbα being highest in the morning. In a mouse Langendorff model of hypoxia-reoxygenation myocardial injury, Rev-Erbα gene deletion or antagonist treatment reduced injury at the time of sleep-to-wake transition, through an increase in the expression of the ischaemia-reperfusion injury modulator CDKN1a/p21.
INTERPRETATION: Perioperative myocardial injury is transcriptionally orchestrated by the circadian clock in patients undergoing aortic valve replacement, and Rev-Erbα antagonism seems to be a pharmacological strategy for cardioprotection. Afternoon surgery might provide perioperative myocardial protection and lead to improved patient outcomes compared with morning surgery. FUNDING: Fondation de France, Fédération Française de Cardiologie, EU-FP7-Eurhythdia, Agence Nationale pour la Recherche ANR-10-LABX-46, and CPER-Centre Transdisciplinaire de Recherche sur la Longévité.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29107324     DOI: 10.1016/S0140-6736(17)32132-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  81 in total

1.  High-accuracy determination of internal circadian time from a single blood sample.

Authors:  Nicole Wittenbrink; Bharath Ananthasubramaniam; Mirjam Münch; Barbara Koller; Bert Maier; Charlotte Weschke; Frederik Bes; Jan de Zeeuw; Claudia Nowozin; Amely Wahnschaffe; Sophia Wisniewski; Mandy Zaleska; Osnat Bartok; Reut Ashwal-Fluss; Hedwig Lammert; Hanspeter Herzel; Michael Hummel; Sebastian Kadener; Dieter Kunz; Achim Kramer
Journal:  J Clin Invest       Date:  2018-08-06       Impact factor: 14.808

Review 2.  Role of the circadian system in cardiovascular disease.

Authors:  Saurabh S Thosar; Matthew P Butler; Steven A Shea
Journal:  J Clin Invest       Date:  2018-06-01       Impact factor: 14.808

Review 3.  Cardiac surgery 2017 reviewed.

Authors:  Torsten Doenst; Hristo Kirov; Alexandros Moschovas; David Gonzalez-Lopez; Rauf Safarov; Mahmoud Diab; Steffen Bargenda; Gloria Faerber
Journal:  Clin Res Cardiol       Date:  2018-05-17       Impact factor: 5.460

4.  Population-level rhythms in human skin with implications for circadian medicine.

Authors:  Gang Wu; Marc D Ruben; Robert E Schmidt; Lauren J Francey; David F Smith; Ron C Anafi; Jacob J Hughey; Ryan Tasseff; Joseph D Sherrill; John E Oblong; Kevin J Mills; John B Hogenesch
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-30       Impact factor: 11.205

Review 5.  Emerging relevance of circadian rhythms in headaches and neuropathic pain.

Authors:  Mark J Burish; Zheng Chen; Seung-Hee Yoo
Journal:  Acta Physiol (Oxf)       Date:  2018-07-25       Impact factor: 6.311

6.  Surgery: Circadian rhythms influence surgical outcomes.

Authors:  Gregory B Lim
Journal:  Nat Rev Cardiol       Date:  2017-11-16       Impact factor: 32.419

7.  The circadian clock in cardiovascular regulation and disease: Lessons from the Nobel Prize in Physiology or Medicine 2017.

Authors:  Linda W Van Laake; Thomas F Lüscher; Martin E Young
Journal:  Eur Heart J       Date:  2018-06-21       Impact factor: 29.983

Review 8.  An overview of the emerging interface between cardiac metabolism, redox biology and the circadian clock.

Authors:  Rodrigo A Peliciari-Garcia; Victor Darley-Usmar; Martin E Young
Journal:  Free Radic Biol Med       Date:  2018-02-10       Impact factor: 7.376

9.  Core Concept: Emerging science of chronotherapy offers big opportunities to optimize drug delivery.

Authors:  David Adam
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-29       Impact factor: 11.205

10.  Frontline Science: Rev-Erbα links blue light with enhanced bacterial clearance and improved survival in murine Klebsiella pneumoniae pneumonia.

Authors:  John E Griepentrog; Xianghong Zhang; Anthony J Lewis; Gianmarino Gianfrate; Hanna E Labiner; Baobo Zou; Zeyu Xiong; Janet S Lee; Matthew R Rosengart
Journal:  J Leukoc Biol       Date:  2019-08-04       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.